These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 27358757)

  • 1. Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals.
    Kristensen M; Nielsen HM
    Tissue Barriers; 2016; 4(2):e1178369. PubMed ID: 27358757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-Penetrating Peptides as Carriers for Oral Delivery of Biopharmaceuticals.
    Kristensen M; Nielsen HM
    Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):99-106. PubMed ID: 26525297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein Cargos.
    Kristensen M; Birch D; Mørck Nielsen H
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive insulin delivery: the great potential of cell-penetrating peptides.
    Kamei N; Nielsen EJ; Khafagy el-S; Takeda-Morishita M
    Ther Deliv; 2013 Mar; 4(3):315-26. PubMed ID: 23442079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.
    Kamei N; Bech Nielsen EJ; Nakakubo T; Aoyama Y; Rahbek UL; Pedersen BL; Takeda-Morishita M
    J Pharm Sci; 2016 Feb; 105(2):747-753. PubMed ID: 26869427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
    Shi NQ; Qi XR; Xiang B; Zhang Y
    J Control Release; 2014 Nov; 194():53-70. PubMed ID: 25151981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-mediated protein delivery-which pathways are penetrable?
    Räägel H; Säälik P; Pooga M
    Biochim Biophys Acta; 2010 Dec; 1798(12):2240-8. PubMed ID: 20170627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral biodrug delivery using cell-penetrating peptide.
    Khafagy el-S; Morishita M
    Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides.
    Kamei N; Takeda-Morishita M
    J Control Release; 2015 Jan; 197():105-10. PubMed ID: 25445695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer.
    Bolhassani A
    Biochim Biophys Acta; 2011 Dec; 1816(2):232-46. PubMed ID: 21840374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses.
    Zappavigna S; Misso G; Falanga A; Perillo E; Novellino E; Galdiero M; Grieco P; Caraglia M; Galdiero S
    Curr Pharm Biotechnol; 2016; 17(8):700-22. PubMed ID: 27087493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
    Feni L; Neundorf I
    Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a non-covalent cell-penetrating peptide strategy to enhance the nasal delivery of interferon beta and its PEGylated form.
    Iwase Y; Kamei N; Khafagy el-S; Miyamoto M; Takeda-Morishita M
    Int J Pharm; 2016 Aug; 510(1):304-10. PubMed ID: 27343364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.
    Kurrikoff K; Gestin M; Langel Ü
    Expert Opin Drug Deliv; 2016; 13(3):373-87. PubMed ID: 26634750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the Key Factors for Optimizing the in Vivo Oral Delivery of Insulin by Using a Noncovalent Strategy with Cell-Penetrating Peptides.
    Kamei N; Shigei C; Hasegawa R; Takeda-Morishita M
    Biol Pharm Bull; 2018; 41(2):239-246. PubMed ID: 29386483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.
    He H; Sun L; Ye J; Liu E; Chen S; Liang Q; Shin MC; Yang VC
    J Control Release; 2016 Oct; 240():67-76. PubMed ID: 26514292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeation.
    Kristensen M; de Groot AM; Berthelsen J; Franzyk H; Sijts A; Nielsen HM
    Bioconjug Chem; 2015 Mar; 26(3):477-88. PubMed ID: 25611217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain.
    Sharma G; Lakkadwala S; Modgil A; Singh J
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells.
    Ma DX; Shi NQ; Qi XR
    Int J Pharm; 2011 Oct; 419(1-2):200-8. PubMed ID: 21843610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.